Andreas Hilbig

973 citations
29 papers · 782 · h-index 17

Impact in

    • Venous Thromboembolism Diagnosis and Management
  • Oncology top 10%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies

Papers in

    • Pancreatic and Hepatic Oncology Research 14
    • Cancer Cells and Metastasis 6
    • Colorectal Cancer Treatments and Studies 6
    • Cancer Treatment and Pharmacology 3
    • Lung Cancer Treatments and Mutations 6
    • Renal cell carcinoma treatment 2

Andreas Hilbig

29 papers receiving 767 citations

Peers

Andreas Hilbig
Comparison fields: 5 of 65
  • Internal Medicine 155
  • Oncology 329
  • Emergency Medical Services 61
  • Cancer Research 115
  • Cardiology and Cardiovascular Medicine 60
Replace Pekka J. Matsi with:
Pekka J. Matsi Finland
Jihong Zhao China
Venkatesh Krishnasamy United States
Camille Brasselet France
Mirjana Radosevic France
Jan David Hohmann Australia
Miet Peeters Belgium
Adrian Padurean United States
Lucie Krenek United States
Andreas Hilbig relative to Pekka J. Matsi Finland Pekka J. Matsi's profile →
Citations per field
00.5×4.1×
Pekka J. Matsi · 1×
Citations per year

Countries citing papers authored by Andreas Hilbig

Since Specialization
Citations

This map shows the geographic impact of Andreas Hilbig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Hilbig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Hilbig more than expected).

Fields of papers citing papers by Andreas Hilbig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Hilbig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Hilbig. The network helps show where Andreas Hilbig may publish in the future.

Co-authors

The 25 scholars most cited alongside Andreas Hilbig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andreas Hilbig Line = papers co-authored together Andreas Hilbig links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2008100
2 200989
3 200868
4 200566
5 200661
6 200952
7 200438
8 200838
9 201133
10 200927
11 201326
12 200626
13 201322
14 201121
15 200919
16 201418
17 200717
18 200716
19 200913
20 20088

About Andreas Hilbig

Andreas Hilbig is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Internal Medicine, having authored 29 papers that have together received 782 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (14 papers), Cancer Cells and Metastasis (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Genomics and Diagnostics (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Cancer Treatment and Pharmacology (3 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Internal Medicine (155 citations), Oncology (329 citations), Emergency Medical Services (61 citations), Cancer Research (115 citations) and Cardiology and Cardiovascular Medicine (60 citations). Andreas Hilbig has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Helmut Oettle, Jens Stieler, Uwe Pelzer, Hanno Riess, Bernd Dörken, Bernhard Opitz, Ingo Schwaner, Sonja Kandel, Patrik Rogalla and Christian Kloeters. Their work appears in journals such as Journal of Clinical Oncology, Expert Review of Anticancer Therapy, BMC Cancer, Frontiers in Oncology and European Radiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact